Research has found that tesamorelin can increase glucose intolerance [23]
Dosing 1 capsule 1-2 times daily on an empty stomach or as directed
Understanding what to expect and how to respond helps maintain productive protocols without unnecessary discontinuation
Reported Sex-Based Variability in the Literature Where sex-based data does appear, researchers generally attribute observed variability to differences in baseline endogenous IGF-1 and growth hormone signaling between male and female physiology, rather than to any fundamental difference in how IGF-1 LR3 binds or activates the IGF-1 receptor
For weight loss specifically, tesamorelin is not FDA-approved, and it does not drive the kind of scale-level reduction that GLP-1s produce
Melatonin has been reported to bind KEAP1, thereby disrupting this interaction and permitting NRF2 to translocate to the nucleus where it can activate antioxidant response element (ARE)-driven gene expression (25, 41, 62, 63)